Hengrui Pharma (01276) has announced that on April 16, 2026, its board of directors elected Mr. Sun Piaoyang as the chairman of the tenth board of directors. The board also elected Mr. Dai Hongbin as the vice chairman of the tenth board. Upon the chairman's nomination, Ms. Feng Ji has been appointed as the company's president and chief operating officer, while Ms. Liu Xiaohan has been appointed as the board secretary. Following the president's nomination, Mr. Zhang Lianshan and Mr. Jiang Ningjun have been appointed as executive vice presidents. Mr. Sun Jieping and Mr. Zhu Guoxin have been appointed as senior vice presidents. Mr. Liu Jianjun has been appointed as the chief financial officer. Additionally, Mr. Tian Fei has been appointed as the company's securities affairs representative.